Contact:
Emma Pautler
Director of Marketing
Global Delaware
302.577.8464
Emma.Pautler@delaware.gov
Wilmington, DE – A delegation from Europe’s leading science and healthcare clusters will meet with distinguished Delaware researchers, industry professionals and entrepreneurs to discuss exciting work being done here in bioscience, cancer research and healthcare fintech. The event will be held on Friday, June 16 at the Delaware Innovation Space (www.deinnovates.org) business incubator and research institute at the DuPont Experimental Station.
The European delegates represent bioXclusters+, the leading European meta-cluster on personalized healthcare. bioXclusters+ brings together four of the fastest-growing life science and healthcare clusters in Europe and representing 3,300 small and medium enterprises (SMEs) in the areas of personalized medicine, oncology, cardiovascular, inflammatory, infectious diseases and the central nervous system.
They will attend this exclusive one-day event en route to the International BIO Convention in San Diego. Organized in collaboration with the Enterprise Europe Network, European American Enterprise Council and French American Chamber of Commerce, the event gives Delaware the opportunity to showcase its competitive advantages for bioscience businesses and to give local companies and institutes the chance to explore collaboration opportunities with their European counterparts.
“Delaware has much to offer international bioscience companies looking for a gateway to the U.S. market and for collaboration opportunities with U.S. companies and researchers,” said Secretary of State Jeff Bullock. “We look forward to sharing information about our resources, domain experts and entrepreneurial community with our guests at DISI.”
Delaware Innovation Space President and CEO Bill Provine will give delegation members a guided tour of the facilities, which will soon include laboratory suites, shared open laboratory space, premium lab equipment, hands-on support services, and shared-use conference rooms.
Secretary Bullock and New Castle County Executive Matt Meyer will welcome delegates at a networking lunch, followed by an afternoon of roundtable discussion with local experts. Topics will include bioscience innovation in Delaware and opportunities for collaboration; an exciting cancer research project involving gene editing currently underway at the Helen F. Graham Cancer Center; and how distributed ledger technology can be used to manage and share healthcare records more safely and efficiently.
Some of Delaware’s most influential and innovative bioscience professionals will be on-hand for the discussion. “This is a unique opportunity for delegates to connect with an exceptional group of professionals and to appreciate what Delaware can offer the international bioscience community,” said Helen Stimson, President of the Delaware Bioscience Association.
“Delaware has the whole package: cutting-edge facilities, an engaged team of public officials, a dynamic community of scientific and business experts, and the quality of life that companies seek when looking to start up new operations,” says Bill Provine. “We look forward to engaging with our guests and showcasing for them the value that Delaware can deliver.”
About the Delaware Innovation Space
The Delaware Innovation Space, Inc. (DEinnovates.org) is a non-profit corporation for scientific entrepreneurship, based in Wilmington, Del. And formed from a partnership between the State of Delaware, DuPont and the University of Delaware. It is a catalyst for the growth of science-based businesses, providing entrepreneurs with state-of-the-art research space, business training and tools as they progress their ideas from concepts to commercial realities.
About Global Delaware
Global Delaware is an international economic development initiative of the Department of State. It plays a vital role in transforming the State’s economy and building a prosperous global center for innovation by helping Delaware companies develop markets overseas, attracting international companies to locate in Delaware, and promoting Delaware’s role as the worldwide leader in corporate governance.
Contact:
Emma Pautler
Director of Marketing
Global Delaware
302.577.8464
Emma.Pautler@delaware.gov
Wilmington, DE – A delegation from Europe’s leading science and healthcare clusters will meet with distinguished Delaware researchers, industry professionals and entrepreneurs to discuss exciting work being done here in bioscience, cancer research and healthcare fintech. The event will be held on Friday, June 16 at the Delaware Innovation Space (www.deinnovates.org) business incubator and research institute at the DuPont Experimental Station.
The European delegates represent bioXclusters+, the leading European meta-cluster on personalized healthcare. bioXclusters+ brings together four of the fastest-growing life science and healthcare clusters in Europe and representing 3,300 small and medium enterprises (SMEs) in the areas of personalized medicine, oncology, cardiovascular, inflammatory, infectious diseases and the central nervous system.
They will attend this exclusive one-day event en route to the International BIO Convention in San Diego. Organized in collaboration with the Enterprise Europe Network, European American Enterprise Council and French American Chamber of Commerce, the event gives Delaware the opportunity to showcase its competitive advantages for bioscience businesses and to give local companies and institutes the chance to explore collaboration opportunities with their European counterparts.
“Delaware has much to offer international bioscience companies looking for a gateway to the U.S. market and for collaboration opportunities with U.S. companies and researchers,” said Secretary of State Jeff Bullock. “We look forward to sharing information about our resources, domain experts and entrepreneurial community with our guests at DISI.”
Delaware Innovation Space President and CEO Bill Provine will give delegation members a guided tour of the facilities, which will soon include laboratory suites, shared open laboratory space, premium lab equipment, hands-on support services, and shared-use conference rooms.
Secretary Bullock and New Castle County Executive Matt Meyer will welcome delegates at a networking lunch, followed by an afternoon of roundtable discussion with local experts. Topics will include bioscience innovation in Delaware and opportunities for collaboration; an exciting cancer research project involving gene editing currently underway at the Helen F. Graham Cancer Center; and how distributed ledger technology can be used to manage and share healthcare records more safely and efficiently.
Some of Delaware’s most influential and innovative bioscience professionals will be on-hand for the discussion. “This is a unique opportunity for delegates to connect with an exceptional group of professionals and to appreciate what Delaware can offer the international bioscience community,” said Helen Stimson, President of the Delaware Bioscience Association.
“Delaware has the whole package: cutting-edge facilities, an engaged team of public officials, a dynamic community of scientific and business experts, and the quality of life that companies seek when looking to start up new operations,” says Bill Provine. “We look forward to engaging with our guests and showcasing for them the value that Delaware can deliver.”
About the Delaware Innovation Space
The Delaware Innovation Space, Inc. (DEinnovates.org) is a non-profit corporation for scientific entrepreneurship, based in Wilmington, Del. And formed from a partnership between the State of Delaware, DuPont and the University of Delaware. It is a catalyst for the growth of science-based businesses, providing entrepreneurs with state-of-the-art research space, business training and tools as they progress their ideas from concepts to commercial realities.
About Global Delaware
Global Delaware is an international economic development initiative of the Department of State. It plays a vital role in transforming the State’s economy and building a prosperous global center for innovation by helping Delaware companies develop markets overseas, attracting international companies to locate in Delaware, and promoting Delaware’s role as the worldwide leader in corporate governance.